ZOLINZA (vorinostat) Msd sub merck Patent: 8,067,472 Expiration: Mar 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Patent E…
Drug Patent Expirations for the Week of February 26, 2023 Read Post »
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-five…
The post New patent for Teva Pharm drug ARMONAIR DIGIHALER a…
New patent for Teva Pharm drug ARMONAIR DIGIHALER Read Post »
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugP…
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Teva Pharm drug ARMONAIR RESPICLICK a…
New patent for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Tablet dosed drug patent expirations by year appeared first on DrugPatentWatch …
This chart shows the generic firms that had the most successful drug patent challenges last year. Companies that successfully challenge patents on branded drugs are granted six months of generic…
The post Most drug patent challenges last year appeared …
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for MEKINIST Mekinist is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nine patents protecting…
The post New patent for Novartis drug MEKINIST appeared first on DrugP…
Annual Drug Patent Expirations for YOSPRALA Yosprala is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Genus Lifesciences drug YOSPRALA ap…
New patent expiration for Genus Lifesciences drug YOSPRALA Read Post »
This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Brazil? Read Post »
Get new actionable insights and updates from BiotechBlog
